Management of Hypertensive Crisis with Labetalol

Initial Assessment and Diagnosis

• The European Society of Cardiology recommends determining if a patient has a hypertensive emergency (with target organ damage) or urgency (without organ damage) by assessing for signs such as hypertensive encephalopathy, acute stroke symptoms, acute coronary syndrome, acute pulmonary edema, and acute renal failure 1
• The International Journal of Stroke suggests assessing for acute stroke symptoms, including focal neurological deficits, to determine the appropriate treatment approach 2

Labetalol Administration and Monitoring

• The American Heart Association recommends measuring baseline blood pressure and heart rate in the supine position before administering labetalol, and monitoring blood pressure every 5 minutes during active dosing, then every 15-30 minutes once stable 2
• The European Heart Journal suggests that labetalol is preferred for hypertensive encephalopathy as it maintains cerebral blood flow and does not increase intracranial pressure 1

Special Clinical Scenarios

• The European Heart Journal recommends labetalol as the drug of choice for stroke-associated hypertension, and suggests reducing blood pressure to <185/110 mmHg before thrombolysis in ischemic stroke, and targeting systolic blood pressure <140 mmHg in hemorrhagic stroke 1, 2
• The International Journal of Stroke suggests that labetalol is an excellent option for acute coronary syndrome, as it reduces myocardial oxygen demand without reflex tachycardia 1

Common Pitfalls and How to Avoid Them

• The Hypertension journal warns that excessive blood pressure reduction can cause end-organ hypoperfusion, and recommends reducing blood pressure by no more than 25% in the first hour 3, 4
• The European Heart Journal suggests avoiding rapid blood pressure drops that could worsen cerebral perfusion in patients with hypertensive encephalopathy 1